Cathay Biotech Inc. (SHA:688065)

China flag China · Delayed Price · Currency is CNY
47.90
+0.57 (1.20%)
Feb 21, 2025, 3:00 PM CST
0.34%
Market Cap 27.85B
Revenue (ttm) 2.76B
Net Income (ttm) 397.82M
Shares Out 581.32M
EPS (ttm) 0.68
PE Ratio 70.39
Forward PE n/a
Dividend 0.19 (0.40%)
Ex-Dividend Date Jul 24, 2024
Volume 5,945,142
Average Volume 4,351,181
Open 47.31
Previous Close 47.33
Day's Range 46.66 - 48.60
52-Week Range 32.48 - 56.98
Beta 0.66
RSI 70.39
Earnings Date Apr 3, 2025

About Cathay Biotech

Cathay Biotech Inc. engages in the production and sale of bio-based polyamide, bio-based DN5, long chain dibasic acids, and biobutanol. The company is headquartered in Shanghai, China. [Read more]

Industry Chemicals
Sector Materials
Founded 2000
Employees 1,803
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688065
Full Company Profile

Financial Performance

In 2023, Cathay Biotech's revenue was 2.11 billion, a decrease of -13.39% compared to the previous year's 2.44 billion. Earnings were 366.52 million, a decrease of -33.75%.

Financial Statements

News

There is no news available yet.